Bernd Harald Liepold

Title: Bernd Harald Liepold: Innovator in Pharmaceutical Formulations

Introduction

Bernd Harald Liepold is a notable inventor based in Ludwigshafen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. With a total of 2 patents, his work focuses on enhancing the bioavailability of pharmaceutical compounds.

Latest Patents

Liepold's latest patents include an immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one. This invention relates to a pharmaceutical formulation that comprises the drug in a solid dispersion with a matrix polymer exhibiting low hygroscopicity and high softening temperature, such as copovidone. The formulation aims to provide a daily pharmaceutical dose of the drug while increasing its bioavailability.

Career Highlights

Throughout his career, Bernd Harald Liepold has worked with prominent companies in the pharmaceutical industry, including Kudos Pharmaceuticals Limited and AstraZeneca AB. His experience in these organizations has contributed to his expertise in drug formulation and development.

Collaborations

Liepold has collaborated with several professionals in the field, including Michael Karl Bechtold and Claudia Bettina Packhaeuser. These collaborations have further enriched his work and innovations in pharmaceutical formulations.

Conclusion

Bernd Harald Liepold is a distinguished inventor whose contributions to pharmaceutical formulations have the potential to significantly impact drug delivery and efficacy. His innovative approaches continue to advance the field of pharmaceuticals.